Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.450
+0.121 (9.09%)
At close: Aug 27, 2025, 4:00 PM
1.490
+0.040 (2.76%)
After-hours: Aug 27, 2025, 6:49 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $4.71 million as of August 27, 2025. Its market cap has increased by 8.36% in one year.
Market Cap
4.71M
Enterprise Value
1.57M
1-Year Change
8.36%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $4.71M, a decrease of -99.96%. That is a compound annual growth rate of -81.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 4.31M | 18.38% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.41B |
| Johnson & Johnson | 425.19B |
| AbbVie | 366.70B |
| UnitedHealth Group | 278.62B |
| Novo Nordisk | 255.49B |
| AstraZeneca | 251.25B |
| Novartis AG | 244.09B |
| Abbott Laboratories | 229.67B |